surmount-1 tirzepatide weight loss nondiabetic SURMOUNT-1: Drastically Reduces in Obese Patients Tirzepatide for the Maintenance of

PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R that predict your receptor sensitivity and peptide pathway function

The upper intake limit for calcium is 2,000-2,500 mg daily (age-dependent), with excessive supplementation potentially associated with cardiovascular and kidney stone risks

These effects can lead to severe cardiac disturbances

Consensus was achieved for 27 out of 50 questions

The SURMOUNT trials demonstrated average weight loss of 22.5% at this level, with 63% of participants losing at least 20% of their body weight

When calories decrease sharply, less energy reaches the follicles